» Articles » PMID: 16831898

Regulation of Lymph Node Vascular Growth by Dendritic Cells

Overview
Journal J Exp Med
Date 2006 Jul 13
PMID 16831898
Citations 102
Authors
Affiliations
Soon will be listed here.
Abstract

Lymph nodes grow rapidly and robustly at the initiation of an immune response, and this growth is accompanied by growth of the blood vessels. Although the vessels are critical for supplying nutrients and for controlling cell trafficking, the regulation of lymph node vascular growth is not well understood. We show that lymph node endothelial cells begin to proliferate within 2 d of immunization and undergo a corresponding expansion in cell numbers. Endothelial cell proliferation is dependent on CD11c+ dendritic cells (DCs), and the subcutaneous injection of DCs is sufficient to trigger endothelial cell proliferation and growth. Lymph node endothelial cell proliferation is dependent on vascular endothelial growth factor (VEGF), and DCs are associated with increased lymph node VEGF levels. DC-induced endothelial cell proliferation and increased VEGF levels are mediated by DC-induced recruitment of blood-borne cells. Vascular growth in the draining lymph node includes the growth of high endothelial venule endothelial cells and is functionally associated with increased cell entry into the lymph node. Collectively, our results suggest a scenario whereby endothelial cell expansion in the draining lymph node is induced by DCs as part of a program that optimizes the microenvironment for the ensuing immune response.

Citing Articles

Inflammation switches the chemoattractant requirements for naive lymphocyte entry into lymph nodes.

Chen K, De Giovanni M, Xu Y, An J, Kirthivasan N, Lu E Cell. 2024; 188(4):1019-1035.e22.

PMID: 39708807 PMC: 11845304. DOI: 10.1016/j.cell.2024.11.031.


ET-3/ETBR Mediates Na-Activated Immune Signaling and Kidney Lymphatic Dynamics.

Mutchler A, Zhong J, Yang H, Zhao S, Crescenzi R, Taylor S Circ Res. 2024; 136(2):194-208.

PMID: 39676651 PMC: 11800760. DOI: 10.1161/CIRCRESAHA.124.324890.


Sphingosine-1-Phosphate Receptor 4 links neutrophils and early local inflammation to lymphocyte recruitment into the draining lymph node to facilitate robust germinal center formation.

Luker A, Wukitch A, Kulinski J, Ganesan S, Kabat J, Lack J Front Immunol. 2024; 15:1427509.

PMID: 39188715 PMC: 11345157. DOI: 10.3389/fimmu.2024.1427509.


Dissociation protocols influence the phenotypes of lymphocyte and myeloid cell populations isolated from the neonatal lymph node.

DaMata J, Zelkoski A, Nhan P, Ennis K, Kim J, Lu Z Front Immunol. 2024; 15:1368118.

PMID: 38756770 PMC: 11097666. DOI: 10.3389/fimmu.2024.1368118.


Targeting hypoxia signaling pathways in angiogenesis.

Monaci S, Coppola F, Filippi I, Falsini A, Carraro F, Naldini A Front Physiol. 2024; 15:1408750.

PMID: 38725568 PMC: 11079266. DOI: 10.3389/fphys.2024.1408750.


References
1.
Hashizume H, Baluk P, Morikawa S, McLean J, Thurston G, Roberge S . Openings between defective endothelial cells explain tumor vessel leakiness. Am J Pathol. 2000; 156(4):1363-80. PMC: 1876882. DOI: 10.1016/S0002-9440(10)65006-7. View

2.
Trowbridge I . Interspecies spleen-myeloma hybrid producing monoclonal antibodies against mouse lymphocyte surface glycoprotein, T200. J Exp Med. 1978; 148(1):313-23. PMC: 2184912. DOI: 10.1084/jem.148.1.313. View

3.
Hemmerich S, Bistrup A, Singer M, van Zante A, Lee J, Tsay D . Sulfation of L-selectin ligands by an HEV-restricted sulfotransferase regulates lymphocyte homing to lymph nodes. Immunity. 2001; 15(2):237-47. DOI: 10.1016/s1074-7613(01)00188-1. View

4.
Palframan R, Jung S, Cheng G, Weninger W, Luo Y, Dorf M . Inflammatory chemokine transport and presentation in HEV: a remote control mechanism for monocyte recruitment to lymph nodes in inflamed tissues. J Exp Med. 2001; 194(9):1361-73. PMC: 2195988. DOI: 10.1084/jem.194.9.1361. View

5.
Luttun A, Tjwa M, Moons L, Wu Y, Angelillo-Scherrer A, Liao F . Revascularization of ischemic tissues by PlGF treatment, and inhibition of tumor angiogenesis, arthritis and atherosclerosis by anti-Flt1. Nat Med. 2002; 8(8):831-40. DOI: 10.1038/nm731. View